SG/CALL/EDWARDS LIFESCIENCES/100/0.1/20.09.24 | Market Closed - Börse Stuttgart 02:28:46 03/07/2024 pm IST | ||
| 0.28 EUR | +12.00% |
|
| Current month | -26.32% | ||
| 1 month | -9.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.28 | +12.00% |
| 02/24/02 | 0.25 | -24.24% |
| 01/24/01 | 0.33 | -13.16% |
| 28/24/28 | 0.38 | +22.58% |
| 27/24/27 | 0.31 | -6.06% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 02:28 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW7EKL |
| ISIN | DE000SW7EKL4 |
| Date issued | 07/03/2024 |
| Strike | 100 $ |
| Maturity | 20/09/2024 (79 Days) |
| Parity | 10 : 1 |
| Emission price | 0.75 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.01 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.05 € |
| Spread % | 15.63% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
